Insider Transactions Reported by 9 Insiders of Petros Pharmaceuticals, Inc.

Symbol
PTPI on OTC
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Petros Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John D. Shulman Director, 10%+ Owner $19,563,156 22 Dec 2021
Joshua N. Silverman Director $44,154 02 Jan 2026
Bruce Bernstein Director $18,873 02 Jan 2026
Fady Boctor President & Chief Commercial Officer $5,199 02 Jan 2026
Wayne R. Walker Director $5,063 02 Jan 2026
Mitchell Arnold Vice Pres. of Finance & Chief Acc. Off. 19 Feb 2025
Andrew Gesek President, Timm Medical 11 May 2021
Metuchen Therapeutics, LLC 10%+ Owner 23 Mar 2021
Greg Bradley Director 21 Dec 2023

Recent Insider Transactions by Companies or Individuals for Petros Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Fady Boctor PTPI Common Stock Award 2501.8% 500,000 519,986 02 Jan 2026 Direct
Joshua Silverman PTPI Common Stock Award 10815.8% 4,375,000 4,415,450 02 Jan 2026 Direct
Wayne Remell Walker PTPI Common Stock Award 7895.2% 500,000 506,333 02 Jan 2026 Direct
Bruce Bernstein PTPI Common Stock Award 15201.9% 1,875,000 1,887,334 02 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.